Jupiter Neurosciences Inc., a clinical-stage pharmaceutical company developing JOTROL, a patented resveratrol-based platform, ...

JUPITER, FL - Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company currently valued at $34.1 million, has announced a partnership with Catalent (NYSE:CTLT) Pharma ...

JOTROL is designed to overcome the historical challenges of resveratrol by significantly enhancing bioavailability while minimizing gastrointestinal side effects. The upcoming Phase 2a trial will ...

Jupiter Neurosciences (JUNS) announced it has entered into an agreement with Catalent Pharma Solutions for the production of JOTROL softgel ...

The approval of Amneal Pharmaceuticals’ generic version of rifaximin 550 mg oral tablets is tentative due to the product’s ...

MIAMI and BARRANQUILLA, Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: PROC) (“Procaps” or the “Company”), a leading ...

Police are asking the community for help after the deadly shooting of a 72-year-old woman in Phoenix Sunday evening. Officers ...

Hyderabad: Granules India, a vertically integrated Indian pharmaceutical company, has announced the resignation of Riaz Ahmed ...

Apotex Inc. ("Apotex" or "the Company"), the largest Canadian-based pharmaceutical company, announced today that it has acquired CanPrev, a leading Canadian provider of vitamins, supplements, and ...

( MENAFN - EIN Presswire) The Caffeine market size was valued at $715.20 million in 2021, and is estimated to reach $1.2 billion by 2031, growing at a CAGR of 5.2% from 2022 to 2031. David Correa ...

Human brains today contain 50% more plastic than in 2016, a new study found. Brain of people diagnosed with dementia had the ...

Introduction Acerola extract, derived from the fruit of Malpighia emarginata, is renowned for its high <a target=_blank href= ...